Managing comorbidities in chronic kidney disease reduces utilization and costs.

Yong Li¹, Kanchan Barve², Meghan Cockrell², Amal Agarwal³, Adrianne Casebeer², Suzanne W Dixon⁴, Insiya Poonawalla⁴

¹Humana Healthcare Research, Humana Inc, 500 W Main Street, Louisville, KY, 40202, USA. yli4@humana.com.

²Humana Inc, 500 W Main Street, Louisville, KY, 40202, USA.

³Affiliated with Humana at the Time of the Work, Current Affiliation Monogram Health, Brentwood, TN, USA.

⁴Humana Healthcare Research, Humana Inc, 500 W Main Street, Louisville, KY, 40202, USA.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Effective management of comorbid diabetes and hypertension in patients with chronic kidney disease (CKD) is important for optimal outcomes. However, little is known about this relationship from a health plan perspective. The objective of this study was to evaluate the association of effective management of comorbid diabetes and/or hypertension with healthcare resource utilization (HCRU…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.